Deborah Birx
Chief Executive Officer bei ARMATA PHARMACEUTICALS, INC.
Vermögen: 2 Mio $ am 31.03.2024
Profil
Deborah L.
Birx is currently the Chief Executive Officer & Director at Armata Pharmaceuticals, Inc. and a Director at Nanolive SA. Previously, she served as an Independent Director at Innoviva, Inc. from 2021 to 2023.
Dr. Birx completed her undergraduate degree at Houghton College in 1976 and obtained her doctorate from Pennsylvania State University College of Medicine in 1980.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
14.03.2024 | 260 000 ( 0,72% ) | 1 Mio $ | 31.03.2024 | |
INNOVIVA, INC.
0,09% | 22.05.2023 | 58 984 ( 0,09% ) | 898 916 $ | 31.03.2024 |
Aktive Positionen von Deborah Birx
Unternehmen | Position | Beginn |
---|---|---|
ARMATA PHARMACEUTICALS, INC. | Chief Executive Officer | 11.07.2023 |
Nanolive SA
Nanolive SA Medical SpecialtiesHealth Technology Nanolive SA develops revolutionary tomographic microscope to look instantly inside living cells in 3D. Its device scans cell division, cell organelles and cell morphology, cell differentiation, cell-cell interaction, intracellular trafficking, cellular remodeling processes, drug monitoring, and in vitro fertilization. The company was founded in November 2013 by Yann Cotte, Sebastien Equis, and Andreas Kern, Fatih Toy, Christian Depeursinge and is headquartered in Ecublens, Switzerland. | Director/Board Member | - |
Ehemalige bekannte Positionen von Deborah Birx
Unternehmen | Position | Ende |
---|---|---|
INNOVIVA, INC. | Director/Board Member | 10.07.2023 |
Ausbildung von Deborah Birx
Houghton College | Undergraduate Degree |
Pennsylvania State University College of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
INNOVIVA, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Nanolive SA
Nanolive SA Medical SpecialtiesHealth Technology Nanolive SA develops revolutionary tomographic microscope to look instantly inside living cells in 3D. Its device scans cell division, cell organelles and cell morphology, cell differentiation, cell-cell interaction, intracellular trafficking, cellular remodeling processes, drug monitoring, and in vitro fertilization. The company was founded in November 2013 by Yann Cotte, Sebastien Equis, and Andreas Kern, Fatih Toy, Christian Depeursinge and is headquartered in Ecublens, Switzerland. | Health Technology |
Armata Pharmaceuticals, Inc. |